HealthEquity, Inc.
HQY$104.63
+$1.19 (1.15%)+1.15%
ClosedLoading chart...
IndexN/A
Market Cap8.75B
Enterprise Value8.06B
Income$0.10B
Sales$1.20B
EmployeesN/A
P/E24.45
P/S5.62
P/B3.50
P/C16.21
EV/EBITDA16.48
EV/SalesN/A
EPS (ttm)4.28
EarningsN/A
Gross Margin69.52%
Oper. Margin24.55%
Profit Margin16.38%
Volume0.50M
Shs Outstand0.08B
Change1.15%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.20B | $999.59M | $861.75M | $756.56M | $733.57M | $531.99M | $287.24M | $229.53M |
| Cost of Revenue | $507.19M | $469.71M | $466.24M | $415.64M | $394.30M | $240.79M | $111.98M | $99.47M |
| Gross Profit | $692.58M | $529.87M | $395.50M | $340.92M | $339.27M | $291.20M | $175.26M | $130.05M |
| Gross Margin | 57.73% | 53.01% | 45.90% | 45.06% | 46.25% | 54.74% | 61.02% | 56.66% |
| Operating Expenses | $462.51M | $401.74M | $357.85M | $300.35M | $259.27M | $182.09M | $97.59M | $75.64M |
| Operating Income | $230.07M | $128.13M | $37.65M | $40.57M | $80.00M | $109.12M | $77.67M | $54.42M |
| Operating Margin | 19.18% | 12.82% | 4.37% | 5.36% | 10.91% | 20.51% | 27.04% | 23.71% |
| Net Income | $96.70M | $55.71M | $-26.14M | $-44.29M | $8.83M | $39.66M | $73.90M | $47.36M |
| Net Margin | 8.06% | 5.57% | -3.03% | -5.85% | 1.20% | 7.46% | 25.73% | 20.63% |
| EPS (Basic) | $1.11 | $0.65 | $-0.31 | $-0.53 | $0.12 | $0.59 | $1.20 | $0.79 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $3.45B | $3.16B | $3.09B | $3.11B | $2.71B | $2.56B | $510.02M | $369.16M |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $1.33B | $1.13B | $1.19B | $1.25B | $1.33B | $1.53B | $32.94M | $22.89M |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $2.11B | $2.04B | $1.90B | $1.85B | $1.38B | $1.03B | $477.08M | $346.27M |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $2.11B | $2.04B | $1.90B | $1.85B | $1.38B | $1.03B | $477.08M | $346.27M |
| Total Liabilities & Stockholders Equity | $3.45B | $3.16B | $3.09B | $3.11B | $2.71B | $2.56B | $510.02M | $369.16M |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Tangible Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $96.70M | $55.71M | $-26.14M | $-44.29M | $8.83M | $39.66M | $73.90M | $47.36M |
| Depreciation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $339.86M | $242.83M | $150.65M | $141.00M | $181.62M | $105.86M | $113.42M | $81.70M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Latest news
HealthEquity, Inc. $HQY Shares Purchased by Amundidefenseworld.net HealthEquity Announces Second Quarter Earnings Release Date and Investor Conference Scheduleglobenewswire.com HealthEquity (HQY) Upgraded to Buy: What Does It Mean for the Stock?zacks.com Castleark Management LLC Purchases New Position in HealthEquity, Inc. $HQYdefenseworld.net HealthEquity's Earnings Momentum Deserves More Creditseekingalpha.com Bank of New York Mellon Corp Lowers Position in HealthEquity, Inc. $HQYdefenseworld.net Why HealthEquity (HQY) is a Top Growth Stock for the Long-Termzacks.com Allspring Global Investments Holdings LLC Lowers Position in HealthEquity, Inc. $HQYdefenseworld.net
Show 12 more stories
Reasons to Hold HealthEquity Stock in Your Portfolio for Nowzacks.com Here's Why HealthEquity (HQY) is a Strong Momentum Stockzacks.com GDRX or HQY: Which Is the Better Value Stock Right Now?zacks.com Here's Why HealthEquity (HQY) is a Strong Growth Stockzacks.com Here's Why HealthEquity (HQY) is a Strong Growth Stockzacks.com Reasons to Hold HealthEquity Stock in Your Portfolio for Nowzacks.com Is HealthEquity's Improving Profitability Enough to Offset Key Risks?zacks.com One in Three Americans Delay Medical Care Due to Cost, HealthEquity Research Findsglobenewswire.com 3 Medical Service Industry Stocks Thriving Amid Workforce Challengeszacks.com 3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)zacks.com Wall Street Analysts See a 33.49% Upside in HealthEquity (HQY): Can the Stock Really Move This High?zacks.com Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Termzacks.com
Insider Trading
View AllInsider
Type
Shares
Price
Value
Date
Company
About the company
Headquartered in Draper, Utah, and established in 2002, HealthEquity, Inc. furnishes technology-powered service platforms to both individual consumers and employers across the United States. The company provides cloud-based solutions designed to assist individuals in overseeing their healthcare expenditures and savings. These platforms enable users to make informed decisions about their health finances, pay medical bills, compare treatment options and costs, access personalized benefits and clinical data, earn incentives for wellness, and grow their savings through various investment avenues, including specific investment choices. In addition to these personal financial management tools, HealthEquity administers a range of health-related accounts, such as Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs). Its offerings also encompass a mutual fund investment platform, an automated online advisory service known as Advisor, COBRA continuation services, and the management of pre-tax commuter benefits programs. HealthEquity markets its services through a dedicated direct sales team, collaborates with benefits brokers and advisors, and leverages a comprehensive network comprising health plans, benefits administrators, consultants, and retirement plan record-keepers.
Discover more
You may be interested in